局所ドラッグデリバリ（局所薬物送達）の世界市場予測（～2021）...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 28)
4.1 Topical Drug Delivery Market, By Route of Administration
4.2 Topical Drug Delivery Market, By Product Type
4.3 Geographic Snapshot of the Topical Drug Delivery Market

5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 High Prevalence of Skin Diseases
5.3.2 Growing Preference for Topical Drug Delivery
5.3.3 High Incidence of Burn Injuries
5.3.4 Rising Incidence of Diabetes
5.3.5 Rising Geriatric Population
5.4 Restraints
5.4.1 Negative Impact of Product Recalls
5.5 Opportunities
5.5.1 Delivery of Biologics Through the Transdermal Route
5.5.2 Acquisition of Small Market Players
5.6 Challenges
5.6.1 Limited Therapeutic Areas of Topical Drug Delivery

6 Topical Drug Delivery Market, By Product Type (Page No. – 38)
6.1 Introduction
6.1.1 Formulations
6.1.1.1 Liquid Topical Formulations
6.1.1.1.1 Solutions
6.1.1.1.2 Suspensions
6.1.1.2 Semi-Solid Topical Formulations
6.1.1.2.1 Creams
6.1.1.2.2 Gels
6.1.1.2.3 Ointments
6.1.1.2.4 Pastes
6.1.1.2.5 Lotions
6.1.1.3 Solid Topical Formulations
6.1.1.3.1 Suppositories
6.1.1.3.2 Powders
6.1.2 Devices (Transdermal Drug Delivery)
6.1.2.1 Transdermal Patches
6.1.2.2 Transdermal Gels

7 Topical Drug Delivery Market, By Route of Administration (Page No. – 53)
7.1 Introduction
7.2 Skin Drug Delivery
7.3 Ophthalmic Drug Delivery
7.4 Rectal Drug Delivery
7.5 Vaginal Drug Delivery
7.6 Nasal Drug Delivery

8 Topical Drug Delivery Market, By Facility of Use (Page No. – 62)
8.1 Introduction
8.2 Hospitals and Private Clinics
8.3 Home Care Settings
8.4 Other Facilities of Use

9 Topical Drug Delivery Market, By Region (Page No. – 67)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of APAC
9.5 Rest of the World

10 Competitive Landscape (Page No. – 99)
10.1 Overview
10.2 Player Ranking
10.3 Competitive Situation and Trends
10.3.1 Product Launches and Approvals
10.3.2 Acquisitions
10.3.3 Agreements & Collaborations
10.3.4 Expansions

11 Company Profiles (Page No. – 106)
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Glaxosmithkline PLC
11.2 Janssen Global Services, LLC. (A Subsidiary of Johnson & Johnson)
11.3 Novartis AG
11.4 Galderma S.A.
11.5 Valeant Pharmaceuticals International, Inc.
11.6 Bayer AG
11.7 3M Drug Delivery Systems
11.8 Crescita Therapeutics Inc.
11.9 Medpharm
11.10 Cipla

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 138)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Available Customizations
12.5 RT: Real-Time Market Intelligence
12.6 Related Reports
12.7 Author Details